DK127788D0 - Farmaceutiske praeparater til anvendelse til behandling eller forebyggelse af sygdomme i mavetarmkanalen - Google Patents

Farmaceutiske praeparater til anvendelse til behandling eller forebyggelse af sygdomme i mavetarmkanalen

Info

Publication number
DK127788D0
DK127788D0 DK127788A DK127788A DK127788D0 DK 127788 D0 DK127788 D0 DK 127788D0 DK 127788 A DK127788 A DK 127788A DK 127788 A DK127788 A DK 127788A DK 127788 D0 DK127788 D0 DK 127788D0
Authority
DK
Denmark
Prior art keywords
diseases
prevention
treatment
gas
pharmaceutical preparations
Prior art date
Application number
DK127788A
Other languages
English (en)
Other versions
DK127788A (da
DK175866B1 (da
Inventor
Geoffrey Place
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21816098&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK127788(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of DK127788D0 publication Critical patent/DK127788D0/da
Publication of DK127788A publication Critical patent/DK127788A/da
Application granted granted Critical
Publication of DK175866B1 publication Critical patent/DK175866B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/345—Nitrofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK198801277A 1987-03-09 1988-03-09 Farmaceutiske præparater til anvendelse til behandling eller forebyggelse af sygdomme i mavetarmkanalen DK175866B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2359687A 1987-03-09 1987-03-09
US2359687 1987-03-09

Publications (3)

Publication Number Publication Date
DK127788D0 true DK127788D0 (da) 1988-03-09
DK127788A DK127788A (da) 1988-09-10
DK175866B1 DK175866B1 (da) 2005-04-18

Family

ID=21816098

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198801277A DK175866B1 (da) 1987-03-09 1988-03-09 Farmaceutiske præparater til anvendelse til behandling eller forebyggelse af sygdomme i mavetarmkanalen

Country Status (13)

Country Link
US (1) US5407688A (da)
EP (2) EP0578965A1 (da)
JP (1) JP2648328B2 (da)
KR (1) KR970007188B1 (da)
AT (1) ATE117206T1 (da)
AU (2) AU621285B2 (da)
CA (1) CA1312012C (da)
DE (1) DE3852773T2 (da)
DK (1) DK175866B1 (da)
IE (2) IE950632L (da)
IL (1) IL85472A (da)
NZ (1) NZ223774A (da)
ZA (1) ZA881678B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0282132B1 (en) * 1987-03-09 1992-09-30 The Procter & Gamble Company Compositions and their use for treating gastrointestinal disorders
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
CH679582A5 (da) * 1988-07-18 1992-03-13 Glaxo Group Ltd
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
EP0403048A3 (en) * 1989-06-14 1991-01-30 Warner-Lambert Company Medicated compositions containing sucralfate and processes for their production
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
KR100193933B1 (ko) * 1990-07-20 1999-06-15 에밀리오 캠포레시, 존 페르구손 비스무트와 폴리아크릴레이트와의 수용성 착체, 이의 제조 방법 및 상기 착체 또는 다른 비스무트염을 함유하는 궤양성 대장염 치료용 약제학적 조성물
GB9018603D0 (en) * 1990-08-24 1990-10-10 Smith Kline French Lab Compositions
WO1992004898A1 (de) * 1990-09-14 1992-04-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Verwendung von pyridylmethylsulfinyl-1h-benzimidazol derivaten zur behandlung durch helicobacter verursachten erkrankungen
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
EP0550083B1 (en) * 1991-12-06 1999-03-24 Glaxo Group Limited Medicaments for treating inflammatory conditions or for analgesia containing a NSAID and ranitidine bismuth citrate
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
IS3990A (is) * 1992-04-24 1993-10-25 Ab Astra Aðferð við að blanda saman efni sem hindrar flæðimagasýru og bakteríueyðandi efnis sem brotnar niður í súru umhverfi
CA2165344A1 (en) * 1993-06-15 1994-12-22 Peter C. Canning Immune stimulants in bacterial infections
WO1996014068A1 (de) * 1994-11-07 1996-05-17 Asche Ag Arzneimittel zur behandlung von erkrankungen des magen-darm-traktes
WO1996016053A1 (en) * 1994-11-21 1996-05-30 Pfizer Pharmaceuticals Inc. Phthalide compounds and their production process
JP3767831B2 (ja) * 1995-06-14 2006-04-19 木村 健 ヘリコバクター・ピロリ除菌用組成物
JP2001526625A (ja) * 1995-11-13 2001-12-18 オールバニ メジカル カレッジ 鎮痛性化合物およびその使用
US5744168A (en) * 1995-12-07 1998-04-28 The Procter & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
WO2000028988A1 (en) 1998-11-17 2000-05-25 Nitromed, Inc. Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
CL2004000983A1 (es) 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
EP1746980B1 (en) 2004-05-07 2011-11-02 Nycomed GmbH Pharmaceutical dosage form comprising pellets as well as its manufacturing process
JP2010518090A (ja) 2007-02-09 2010-05-27 トランザイム・ファーマ，インコーポレイテッド 大環状グレリン受容体修飾因子およびその使用方法
JP2011178722A (ja) * 2010-03-01 2011-09-15 Synmosa Biopharma Corp ヘリコバクタ−・ピロリ（Ｈ．ｐｙｌｏｒｉ）を除菌する医薬組成物及びその製造方法
EP2601947A1 (en) * 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2218883B1 (da) * 1973-02-28 1976-08-13 Science Union & Cie
US4333922A (en) * 1974-09-12 1982-06-08 Herschler R J Method for the treatment of water-living animals with health modifying agents
CH638975A5 (fr) * 1979-07-27 1983-10-31 Prebuilt Ets Composition medicamenteuse pour le traitement des ulceres gastro-duodenaux.
WO1986005981A1 (en) * 1985-04-18 1986-10-23 Borody Thomas J Treatment of non-ulcer dyspepsia with bismuth salts
EP0206627B1 (en) * 1985-06-13 1992-08-12 Barry James Dr. Marshall Methods for the treatment of gastrointestinal disorders
DE3686836T2 (de) * 1985-06-13 1993-03-04 Barry James Marshall Zusammensetzungen zur behandlung von magen-darmstoerungen.
US4959384A (en) * 1985-10-24 1990-09-25 Norwich Eaton Pharmaceuticals, Inc. Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders
EP0282132B1 (en) * 1987-03-09 1992-09-30 The Procter & Gamble Company Compositions and their use for treating gastrointestinal disorders
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
CH679582A5 (da) * 1988-07-18 1992-03-13 Glaxo Group Ltd
DE3830616A1 (de) * 1988-09-09 1990-03-15 Ruetgerswerke Ag Prophylaktikum fuer fische

Also Published As

Publication number Publication date
IE66367B1 (en) 1995-12-27
ZA881678B (en) 1988-09-07
DE3852773T2 (de) 1995-07-06
IE880665L (en) 1988-09-09
ATE117206T1 (de) 1995-02-15
JPS63290831A (ja) 1988-11-28
US5407688A (en) 1995-04-18
DK127788A (da) 1988-09-10
AU1279388A (en) 1988-09-08
EP0578965A1 (en) 1994-01-19
DK175866B1 (da) 2005-04-18
EP0282131A3 (en) 1989-11-15
CA1312012C (en) 1992-12-29
IE950632L (en) 1988-09-09
JP2648328B2 (ja) 1997-08-27
AU621285B2 (en) 1992-03-12
AU1030292A (en) 1992-03-05
KR880011197A (ko) 1988-10-27
KR970007188B1 (ko) 1997-05-07
AU660645B2 (en) 1995-07-06
IL85472A (en) 1991-06-30
EP0282131A2 (en) 1988-09-14
EP0282131B1 (en) 1995-01-18
NZ223774A (en) 1991-02-26
DE3852773D1 (de) 1995-03-02

Similar Documents

Publication Publication Date Title
DK127788D0 (da) Farmaceutiske praeparater til anvendelse til behandling eller forebyggelse af sygdomme i mavetarmkanalen
DK127688D0 (da) Farmaceutiske praeparater til anvendelse til behandling eller forebyggelse af sygdomme i mavetarmkanalen
HK1013993A1 (en) Novel carbamates and ureas as modifiers of multi-drug resistance
CA2158475A1 (en) Composition and method for reducing toxicity of biologically-active factors
NO1994018I1 (no) Mometasonfuroat
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
NO951432D0 (no) Farmasöytiske preparater
DE69927584D1 (de) Pharmazeutische zubereitungen zur behandlung von magengeschwüren
NO894222D0 (no) Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder.
DE58902582D1 (de) Verwendung der pflanze euphorbia hirta l. und ihrer extrakte sowie ihrer wirkstoffe.
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
DK0778028T3 (da) Præparater til forebyggelse og behandling af urogenitale lidelser, der indeholder bismuth og ét eller flere antimikrobielle midler
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
ATE52030T1 (de) Arzneimittel fuer die behandlung und verhuetung von leberschaedigungen.
NO982635D0 (no) Sammensetninger inneholdende vismut og ett eller flere antimikrobielle midler for forebygging og behandling av gastrointestinale forstyrrelser
UA12753A (uk) Спосіб лікуваhhя та профілактики респіраторhих захворюваhь молодhяка сільськогосподарських твариh змішаhої етіології
DE500713T1 (de) Derivate des 3,3,5-trimethylcyclohexylesters von 2-methylpropionsaeure, ihr herstellungsverfahren sowie diese enthaltende therapeutische kompositionen.
NO881798D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO950842L (no) Diarylpiperazinoacetamidforbindelser som antimuskariniske midler
GB8908457D0 (en) Pharmaceutical compositions and uses therefor
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.

Legal Events

Date Code Title Description
PUP Patent expired